12/20
08:30 pm
lly
US Approves First Drug Treatment For Sleep Apnea [Barron's]
Neutral
Report
US Approves First Drug Treatment For Sleep Apnea [Barron's]
12/20
06:33 pm
lly
FDA approves weight-loss drug Zepbound for obstructive sleep apnea [CNN]
Neutral
Report
FDA approves weight-loss drug Zepbound for obstructive sleep apnea [CNN]
12/20
06:01 pm
lly
Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints [Yahoo! Finance]
Neutral
Report
Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints [Yahoo! Finance]
12/20
05:58 pm
lly
FDA approves weight loss drug Zepbound for sleep apnea [MSNBC.com]
Low
Report
FDA approves weight loss drug Zepbound for sleep apnea [MSNBC.com]
12/20
05:41 pm
lly
FDA Approves First Medication for Obstructive Sleep Apnea [Yahoo! Finance]
Neutral
Report
FDA Approves First Medication for Obstructive Sleep Apnea [Yahoo! Finance]
12/20
05:30 pm
lly
Zepbound Approved For Sleep Apnea [Forbes]
Neutral
Report
Zepbound Approved For Sleep Apnea [Forbes]
12/20
05:05 pm
lly
FDA approves weight-loss drug Zepbound for obstructive sleep apnea [CNN]
Low
Report
FDA approves weight-loss drug Zepbound for obstructive sleep apnea [CNN]
12/20
05:03 pm
lly
Eli Lilly's Zepbound gains sleep apnea indication [Seeking Alpha]
Low
Report
Eli Lilly's Zepbound gains sleep apnea indication [Seeking Alpha]
12/20
04:43 pm
lly
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. [CNBC]
Neutral
Report
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. [CNBC]
12/20
04:41 pm
lly
FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity [Yahoo! Finance]
Low
Report
FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity [Yahoo! Finance]
12/20
04:32 pm
lly
FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
Low
Report
FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
12/20
01:35 pm
lly
Novo's Obesity Shot Shortfall Shows Danger of Promising Too Much [Yahoo! Finance Canada]
Low
Report
Novo's Obesity Shot Shortfall Shows Danger of Promising Too Much [Yahoo! Finance Canada]
12/20
11:27 am
lly
LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List [Yahoo! Finance]
Neutral
Report
LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List [Yahoo! Finance]
12/20
09:42 am
lly
Novo Nordisk Falls Most on Record After New Weight Drug Disappoints [Yahoo! Finance Canada]
Medium
Report
Novo Nordisk Falls Most on Record After New Weight Drug Disappoints [Yahoo! Finance Canada]
12/20
08:46 am
lly
FDA confirms end of Eli Lilly's tirzepatide shortage after re-evaluation [Yahoo! Finance]
Low
Report
FDA confirms end of Eli Lilly's tirzepatide shortage after re-evaluation [Yahoo! Finance]
12/20
07:45 am
lly
Indiana Sees $39 Billion Worth of Projects Under Construction, an Industrial Info News Alert
Medium
Report
Indiana Sees $39 Billion Worth of Projects Under Construction, an Industrial Info News Alert
12/20
07:27 am
lly
Novo Nordisk Falls Most on Record After New Weight Drug Disappoints [Yahoo! Finance Canada]
Medium
Report
Novo Nordisk Falls Most on Record After New Weight Drug Disappoints [Yahoo! Finance Canada]
12/20
07:22 am
lly
Novo Nordisk Falls Most on Record After New Weight Drug Disappoints [Yahoo! Finance]
Medium
Report
Novo Nordisk Falls Most on Record After New Weight Drug Disappoints [Yahoo! Finance]
12/20
06:32 am
lly
Novo Nordisk's next-gen obesity drug CagriSema achieves lower weight loss than expected [Yahoo! Finance]
Medium
Report
Novo Nordisk's next-gen obesity drug CagriSema achieves lower weight loss than expected [Yahoo! Finance]
12/19
08:05 pm
lly
In weight loss battle, Novo and Lilly face growing offensive from licenced copies [Yahoo! Finance Canada]
Low
Report
In weight loss battle, Novo and Lilly face growing offensive from licenced copies [Yahoo! Finance Canada]
12/19
08:04 pm
lly
In weight loss battle, Novo and Lilly face growing offensive from licenced copies [Yahoo! Finance]
Low
Report
In weight loss battle, Novo and Lilly face growing offensive from licenced copies [Yahoo! Finance]
12/19
06:55 pm
lly
Mounjaro, Zepbound shortage is over. Here's what you need to know. [USA TODAY]
Low
Report
Mounjaro, Zepbound shortage is over. Here's what you need to know. [USA TODAY]
12/19
05:20 pm
lly
7 Growth Stocks To Buy In 2025 [Forbes]
Low
Report
7 Growth Stocks To Buy In 2025 [Forbes]
12/19
04:06 pm
lly
Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls [Yahoo! Finance]
Low
Report
Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls [Yahoo! Finance]
12/19
03:57 pm
lly
FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next [Yahoo! Finance]
Neutral
Report
FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next [Yahoo! Finance]